Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04498845 · ClinicalTrials.gov registry record · NA
RECLEAN Pilot Study
A NA study, sponsored by Boston University.
- Terminated
- Registry status
- NA
- Development phase
- 35
- Enrollment target
NCT04498845 is a NA study that was terminated before completion, run by Boston University. The registered enrollment target is 35 participants.
The verdict
NCT04498845, a NA study, was terminated before completion, sponsored by Boston University.
- TERMINATED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
Study Summary
This is an exposure assessment pilot study tailored for families of construction workers living with a child. The investigators will compare home dust metal levels and resident's blood metal levels before and after an educational and environmental intervention. A baseline and a post intervention period assessment will be conducted with home and car lead inspections and risk assessments with collection of dust, urine, blood and toenail samples and a survey. Objectives of this research are to: 1. To characterize pre-intervention home exposures to lead and other metals in households with one construction worker inhabitant living with a child, by assessing household members' biospecimens and home dust metal levels. 2. To develop and evaluate customized home interventions (including environmental and educational approaches) to reduce metals exposure in three tiers of intervention. 3. To characterize home exposures to lead and other metals post intervention and determine adapted behaviors and whether the degree of metals exposure reduction (including take home exposures) in the households depends on the level of intervention.
Interventions
- OTHER In-home assessment plan
- BEHAVIORAL Family educational session
- BEHAVIORAL Worker take home prevention training
- OTHER D-LEAD cleaner products
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2021-04-27 |
| Est. Completion | 2024-01-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04498845
The ClinicalTrials.gov registry entry for NCT04498845 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston University, which has 185 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which In-home assessment plan is the first listed.
NCT04498845 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04498845 about?
NCT04498845 is a clinical study titled "RECLEAN Pilot Study". This is an exposure assessment pilot study tailored for families of construction workers living with a child. The investigators will compare home dust metal levels and resident's blood metal levels before and after an educational and environmental intervention. A baseline and a post intervention per...
What is the current status of trial NCT04498845?
This trial is currently terminated. It is a NA study. The enrollment target is 35 participants. The study started on 2021-04-27. Estimated completion is 2024-01-20.
What interventions are being tested in trial NCT04498845?
The interventions under investigation include: In-home assessment plan (OTHER), Family educational session (BEHAVIORAL), Worker take home prevention training (BEHAVIORAL), D-LEAD cleaner products (OTHER).
Who is sponsoring clinical trial NCT04498845?
This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.